pubmed-article:18809327 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18809327 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
pubmed-article:18809327 | lifeskim:mentions | umls-concept:C1421467 | lld:lifeskim |
pubmed-article:18809327 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
pubmed-article:18809327 | lifeskim:mentions | umls-concept:C0243076 | lld:lifeskim |
pubmed-article:18809327 | lifeskim:mentions | umls-concept:C1707689 | lld:lifeskim |
pubmed-article:18809327 | lifeskim:mentions | umls-concept:C0243072 | lld:lifeskim |
pubmed-article:18809327 | pubmed:issue | 20 | lld:pubmed |
pubmed-article:18809327 | pubmed:dateCreated | 2008-10-20 | lld:pubmed |
pubmed-article:18809327 | pubmed:abstractText | 6-Phenylnicotinamide (2) was previously identified as a potent TRPV1 antagonist with activity in an in vivo model of inflammatory pain. Optimization of this lead through modification of both the biaryl and heteroaryl components has resulted in the discovery of 6-(4-fluorophenyl)-2-methyl-N-(2-methylbenzothiazol-5-yl)nicotinamide (32; SB-782443) which possesses an excellent overall profile and has been progressed into pre-clinical development. | lld:pubmed |
pubmed-article:18809327 | pubmed:language | eng | lld:pubmed |
pubmed-article:18809327 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809327 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18809327 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809327 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809327 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809327 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809327 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809327 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18809327 | pubmed:month | Oct | lld:pubmed |
pubmed-article:18809327 | pubmed:issn | 1464-3405 | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:DavisJohn BJB | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:GunthorpeMart... | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:WrightJamesJ | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:StevensAlexan... | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:StempGeoffrey... | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:MedhurstSteph... | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:JermanJeffrey... | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:WinbornKim... | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:ColemanTanyaT | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:MitchellDarre... | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:ThompsonMervy... | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:RamiHarshad... | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:WestawaySusan... | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:HollandVickyV | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:SealJon TJT | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:LappinSarah... | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:ArpinoSandraS | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:TrouwLeontine... | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:BiggsJamesJ | lld:pubmed |
pubmed-article:18809327 | pubmed:author | pubmed-author:CryanJennifer... | lld:pubmed |
pubmed-article:18809327 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18809327 | pubmed:day | 15 | lld:pubmed |
pubmed-article:18809327 | pubmed:volume | 18 | lld:pubmed |
pubmed-article:18809327 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18809327 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18809327 | pubmed:pagination | 5609-13 | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:meshHeading | pubmed-meshheading:18809327... | lld:pubmed |
pubmed-article:18809327 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18809327 | pubmed:articleTitle | Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1. | lld:pubmed |
pubmed-article:18809327 | pubmed:affiliation | Neurology CEDD, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK. sue.m.westaway@gsk.com | lld:pubmed |
pubmed-article:18809327 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:18809327 | lld:chembl |